Holen Sie sich die Stockscreener-App
161.20
2.50%
-4.14
Handel nachbörslich:
161.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$165.34
Offen:
$160.15
24-Stunden-Volumen:
547.19K
Relative Volume:
0.84
Marktkapitalisierung:
$9.32B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$-494.50M
KGV:
-17.48
EPS:
-9.22
Netto-Cashflow:
$137.20M
1W Leistung:
-6.26%
1M Leistung:
-0.22%
6M Leistung:
-8.48%
1J Leistung:
+20.43%
1-Tages-Spanne:
$157.54
$163.24
1-Wochen-Bereich:
$157.54
$174.50
52-Wochen-Spanne:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Vergleichen Sie MASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
161.20 | 9.32B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
135.62 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
99.74 | 151.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.30 | 146.71B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.27 | 112.09B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.15 | 45.47B | 5.54B | 4.18B | 623.10M | 7.00 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Multiple Executive Changes Announced by Masimo; COO Muhsin to Resign July 1 - Strata-gee.com
Masimo COO to Resign - Orange County Business Journal
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - GlobeNewswire Inc.
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - marketscreener.com
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia – Company AnnouncementFT.com - Financial Times
New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker - Orange County Business Journal
Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand - Law360
Masimo Corp (MASI) Stock Price Up 3.31% on Jun 6 - GuruFocus
Transcript : Masimo Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - marketscreener.com
Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
BTIG maintains Buy on Masimo stock with $193 price target - Investing.com India
BTIG maintains Buy on Masimo stock with $193 price target By Investing.com - Investing.com Canada
Masimo Founder Slaps Board With Lawsuit Over His Ouster - Law360
Is the Market Bullish or Bearish on Masimo? - Benzinga
Masimo Updates SEC on Its Progress Recovering From Recent Cyberattack - Strata-gee.com
Masimo (MASI) Reaffirms 2025 Outlook Despite Cybersecurity Incident - GuruFocus
Masimo Corporation: Will The Sound United Divestiture & Financial Realignment Efforts Meet Their Ultimate Goal? - Smartkarma
Masimo Corp (MASI) Trading 3.93% Higher on May 27 - GuruFocus
Masimo (MASI) Reassures Investors on Financial Outlook | MASI Stock News - GuruFocus
Masimo Corp maintains outlook despite cyber incident By Investing.com - Investing.com South Africa
Masimo Corp maintains outlook despite cyber incident - Investing.com
Masimo Leadership Takes Stage at Jefferies Healthcare Conference: Key Investor Presentation Coming June 4 - Stock Titan
MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds - Yahoo Finance
Midday Stock Roundup: RxSight Up 13% on Wells Fargo Upgrade - Orange County Business Journal
Masimo Tells SEC It Was the Victim of a Cyberattack - Strata-gee.com
Masimo Sells Sound United to Harman; Excited? Temper Your Enthusiasm - Strata-gee.com
Transcript : Masimo Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com
Masimo at BofA Healthcare Conference: Strategic Realignment for Growth - Investing.com
Recent Investment Analysts’ Ratings Changes for Masimo (MASI) - Defense World
Do You Believe in the Growth Potential of Masimo Corporation (MASI)? - MSN
INVESTOR ALERT: Potential Recovery for Masimo Corporation (MASI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Masimo Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineMASI - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Masimo Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 23, 2023MASI - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Reminds Masimo Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 23, 2023MASI - ACCESS Newswire
Masimo Adds to Patient Monitoring Business with Phasein Purchase - Medical Product Outsourcing
Sounds of relief as Masimo unloads audio division - BioWorld MedTech
Masimo to Sell Consumer Audio Business to HARMAN for $350 Million - rAVe [PUBS]
Top medical device maker Masimo confirms cyberattack, says products may be delayed - TechRadar
Samsung’s HARMAN Acquiring Masimo’s Sound United - WebProNews
Masimo faces operational disruption after cybersecurity breach, triggers law enforcement coordination - Industrial Cyber
Masimo Manufacturing Facilities Hit by Cyberattack - SecurityWeek
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes" - Nasdaq
Stifel cuts Masimo stock price target to $180 from $190 By Investing.com - Investing.com South Africa
Masimo Corp’s Q1 2025 Earnings Call Highlights - TipRanks
Masimo stock price target cut to $193 by BTIG - Investing.com Nigeria
Patient Monitor Manufacturer Is Still Recovering From Attack - Bank Info Security
Masimo (MASI) Price Target Reduced by Raymond James While Mainta - GuruFocus
Masimo (MASI) Analyst Rating and Price Target Update | MASI Stoc - GuruFocus
Stifel cuts Masimo stock price target to $180 from $190 - Investing.com Australia
Masimo Divests Sound United, Shifts Focus Back to Healthcare Tech - Medical Device and Diagnostic industry
Masimo Unloads Embattled Audio Unit In $350M Sale - Law360
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.68%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):